Human Immunodeficiency Virus Glycoprotein gp120 as the Primary Target for the Antiviral Action of AR177 (Zintevir)

  • José A. Esté, Cecilia Cabrera, Dominique Schols, Peter Cherepanov, Arantxa Gutierrez, Myriam Witvrouw, Christophe Pannecouque, Zeger Debyser, Robert F. Rando, Bonaventura Clotet, Jan Desmyter, Erik De Clercq
  • Molecular Pharmacology, February 1998, American Society for Pharmacology & Experimental Therapeutics (ASPET)
  • DOI: 10.1124/mol.53.2.340

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1124/mol.53.2.340